Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.40 USD
Change Today -0.0299 / -6.95%
Volume 169.0K
DCTH On Other Exchanges
DCTH is not on other exchanges.
As of 5:20 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Eamonn P. Hobbs

AgeTotal Calculated CompensationThis person is connected to 54 board members in 6 different organizations across 8 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Eamonn P. Hobbs has been the Chief Executive Officer and President of Antares Pharma Inc., since June 23, 2014. Mr. Hobbs served as the Chief Executive Officer and President of Delcath Systems, Inc. from July 2009 to September 10, 2013. He Co-founded AngioDynamics Inc., a subsidiary of E-Z-EM Inc. and served as its Chief Executive Officer and President from June 1996 to March 1, 2009. He served as Senior Vice President of Angio Dynamics since October 2002 and its ...

Read Full Background

Corporate Headquarters*

1301 Avenue of the Americas
New York, New York 10019

United States

Phone: 212-489-2100
Fax: 212-489-2102

Board Members Memberships*

Vice Chairman
Board Chair
Chief Executive Officer, President and Director


BS 1980
University of Massachusetts Lowell

Other Affiliations*

Annual Compensation*

Total Annual Compensation$292,923

Stock Options*

Restricted Stock Awards$798,300
All Other Compensation$40,524
Exercisable Options213,333
Exercisable Options Value$128,900
Unexercisable Options416,667
Total Value of Options$128,900
Total Number of Options630,000

Total Compensation*

Total Annual Cash Compensation$359,875
Total Short Term Compensation$292,923
Other Long Term Compensation$838,824
Total Calculated Compensation$2,020,175
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DCTH:US $0.40 USD -0.0299


Tony K. Chow Chief Executive Officer, President and Director
Bioject Medical Technologies Inc.
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
Eric M. Green Chief Executive Officer and Director
West Pharmaceutical Services, Inc.
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
Simon Michel Chief Executive Officer
Ypsomed Holding AG
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DELCATH SYSTEMS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at